Lantheus Completes Merger with Progenics

June 22, 2020 – Lantheus Holdings, Inc., the parent company of Lantheus Medical Imaging, Inc., announces completion of merger with Progenics Pharmaceuticals, Inc. Learn More

See the Difference

Improved diagnostic information for better patient management

Learn More

Play Video

See the Difference

Brands you know; Quality you trust; Reliability you demand daily

Learn More

See the Difference

Advancing the art of science and imaging

Learn More

News

Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL™ (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent

Read More

Lantheus Holdings to Present at the Wells Fargo 2020 Virtual Healthcare Conference

Read More

Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX® RFID Device for DEFINITY®

Read More

Coronavirus (COVID-19) Updates

Providing you with important information regarding our response to the C0VID-19 pandemic.
(updated 5/29/2020)

View a recent Lantheus webinar:
COVID-19: Clinical Experiences from the Front Line in NYC

Read More

News

Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL™ (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent

Read More

Lantheus Holdings to Present at the Wells Fargo 2020 Virtual Healthcare Conference

Read More

Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX® RFID Device for DEFINITY®

Read More

callout_technicians

About Us

At Lantheus, we develop, manufacture and commercialize essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care.

Learn More

callout_product

Spotlight

Setting the standard for diagnostic quality, safety and commitment with the leading echocardiography contrast agent in North America.

Learn More

 

callout scientist

Pipeline

We are developing next generation imaging agents to enhance the accuracy, reliability and safety of diagnostic imaging.

Learn More

 

callout_product

Spotlight

Setting the standard for diagnostic quality, safety and commitment with the leading echocardiography contrast agent in North America.

Learn More